[ad_1]
The group of elite megacap stocks isn’t outperforming its S&P 500 peers for the first time in nearly two years, according to BMO.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...